CDK7 and MITF Repress a Transcription Program Involved in Survival and Drug Tolerance in Melanoma

The authors showed that dedifferentiation of melanocytic-type melanoma cells into mesenchymal-like cells and acquisition of tolerance to targeted therapies was achieved through chronic inhibition of CDK7.